| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4023832 | Journal Français d'Ophtalmologie | 2012 | 5 Pages |
Abstract
We report a case of central serous chorioretinopathy in a 46-year-old man with no risk factors except for erectile dysfunction agent use: Tadalafil (Cialis®). An association between tadalafil and central serous chorioretinopathy could involve phosphodiesterase type 5 inhibitors and be a risk factor of central serous chorioretinopathy.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
S. Nadeau, F. Nguyen, S. Guigou,